The Aspergillus Niger Causing Eumycetoma in an Immunocompetent Host: Report of a Case and Review of the Literature

Eumycetoma caused by Aspergillus niger

Authors

  • Yousuf Abd Mallick The Indus Hospital
  • Nausheen Yaqoob The Indus Hospital, Karachi, Pakistan

DOI:

https://doi.org/10.36570/jduhs.2020.1.809

Keywords:

Mycetoma, Eumycetoma, Aspergillus niger, Voriconazole, dot-in-circle sign

Abstract

Mycetoma is a chronic granulomatous infection of skin and subcutaneous tissues. It is a neglected disease with severe physical and psychological comorbidity burden as many cases end up with amputations. Proper diagnosis with tissue culture is lacking because of unavailability of facilities in remote areas. Eumycetoma by different Aspergillus species has already been reported in the literature for decades. But here, we are reporting a case of eumycetoma caused by Aspergillus niger, which is the first ever case-report to the best of our knowledge and search. Treatment with voriconazole 400 mg/day was successful without any major side-effects, and saved patient from amputation.

Downloads

Download data is not yet available.

Author Biography

Nausheen Yaqoob, The Indus Hospital, Karachi, Pakistan

Section Head and Senior Consultant Histopathologist,
Pathology Unit,
The Indus Hospital, Karachi, Pakistan.

Downloads

Additional Files

Published

2020-04-27

How to Cite

Mallick, Y. A., & Yaqoob, N. (2020). The Aspergillus Niger Causing Eumycetoma in an Immunocompetent Host: Report of a Case and Review of the Literature: Eumycetoma caused by Aspergillus niger. Journal of the Dow University of Health Sciences (JDUHS), 14(1), 42–44. https://doi.org/10.36570/jduhs.2020.1.809

Issue

Vol. 14 No. 1

Section

Case Report

License

Copyright (c) 2019 Yousuf Abd Mallick, Nausheen Yaqoob

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal.